Page last updated: 2024-11-07

dehydroepiandrosterone and Neuroendocrine Tumors

dehydroepiandrosterone has been researched along with Neuroendocrine Tumors in 1 studies

Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.

Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ziegler, CG1
Sicard, F1
Lattke, P1
Bornstein, SR1
Ehrhart-Bornstein, M1
Krug, AW1

Other Studies

1 other study available for dehydroepiandrosterone and Neuroendocrine Tumors

ArticleYear
Dehydroepiandrosterone induces a neuroendocrine phenotype in nerve growth factor-stimulated chromaffin pheochromocytoma PC12 cells.
    Endocrinology, 2008, Volume: 149, Issue:1

    Topics: Adrenal Gland Neoplasms; Animals; Biomarkers; Cell Differentiation; Cell Survival; Chromaffin Cells;

2008